可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 张美芳,何巍,俞锋,等. C反应蛋白和冠心病的关系[J]. 心脏杂志,2003,15(1):19.
[2]Libby P. Inflammation in atherosclerosis[J]. Nature,2002,420(6917):868-874.
[3]Williams KJ, Tabas I. Atherosclerosis and inflammation[J]. Science,2002,297(5581):521-522.
[4]Blankenberg S, Luc G, Ducimetiere P,et al. PRIME study group. interleukin18 and the risk of coronary heart disease in European men: the prospective epidemiological study of myocardial infarction (PRIME) [J]. Circulation, 2003, 108 (20):2453-2459.
[5]Blankenberg S, Tiret L, Bickel C, et al. Interleukin18 is a strong predictor of cardiovascular death in stable and unstable angina[J]. Circulation, 2002,106(1):24-30.
[6]Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFNgamma production by T cells[J].Nature,1995,378(6552):88-91.
[7]Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFNgammainducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. [J]. Immunol,1996,156(11):4274-4279.
[8]Whitman SC, Ravisankar P, Daugherty A. Interleukin18 enhances atherosclerosis in apolipoprotein E(/) mice through release of interferongamma[J]. Circ Res,2002,90(2):E34-E38.
[9]Elhage R, Jawien J, Rudling M, et al. Reduced atherosclerosis in interleukin18 deficient apolipoprotein Eknockout mice[J]. Cardiovasc Res,2003,59(1):234-240.
[10]Mallat Z, Corbaz A, Scoazec A, et al .Interleukin18/interleukin18 binding protein signaling modulates atherosclerotic lesion development and stability[J]. Circ Res,2001,89(7):E41-E45.
[11]Seta Y, Kanda T, Tanaka T, et al. Interleukin 18 in acute myocardial infarction[J]. Heart, 2000,84(6):668.